INFLAMMATORY RESPONSE TO DIETS BETWEEN ASIANS AND CAUCASIANS
亚洲人和白人对饮食的炎症反应
基本信息
- 批准号:7606949
- 负责人:
- 金额:$ 0.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The hypothesis of this study is that Asian Americans compared to Caucasians, will be at higher risk of developing a pro-inflammatory state that may contribute to the development of heart disease and diabetes when they change from a traditional Asian diet to a typical American diet. These inflammatory responses will be reflected by the activation of monocytes as measured by protein kinase C (PKC), a known activator of monocytes. It is hypothesized that these inflammatory responses in the gingival crevicular fluid (GCF) will reflect similar changes of these markers in the plasma and monocytes. The specific aims of this study are to compare the inflammatory responses (primary PKC activation in monocytes), between Far-East Asian Americans and Caucasian Americans, when they change from a traditional Asian diet to a typical American diet and also to correlate the biochemical changes of inflammatory responses in the plasma and monocytes with those in the gingival crevicular fluid.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
这项研究的假设是,与高加索人相比,亚裔美国人将面临促炎性状态的风险更高,当他们从传统的亚洲饮食变为典型的美国饮食时,可能会导致心脏病和糖尿病的发展。这些炎症反应将通过单核细胞的激活来反映,如蛋白激酶C(PKC)测量,蛋白激酶C(PKC)是已知的单核细胞活化剂。假设在牙龈裂缝液(GCF)中的这些炎症反应将反映出血浆和单核细胞中这些标记的类似变化。这项研究的具体目的是比较遥远的美国人和高加索的美国人之间的炎症反应(单核细胞中的主要PKC激活),当他们从传统的亚洲饮食变为典型的美国饮食,并将血浆和单核细胞炎症中炎症反应的生物化学变化与这些杂种的生化反应相关联。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
GEORGE L KING的其他基金
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
- 批准号:1051127610511276
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
- 批准号:1070951810709518
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
- 批准号:1054399410543994
- 财政年份:2021
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
- 批准号:1037246210372462
- 财政年份:2021
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy
丙酮酸激酶 M2 水平和激活作为糖尿病肾病的保护因素
- 批准号:92357479235747
- 财政年份:2016
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
- 批准号:1032003410320034
- 财政年份:2016
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
- 批准号:1054374610543746
- 财政年份:2016
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Identification of Retinoid-Binding Protein 3 (RBP3): A Protective Factor against Diabetic Retinopathy Using Retina from People with Extreme Duration of Diabetes
类维生素A结合蛋白3 (RBP3)的鉴定:利用糖尿病病程极长的人的视网膜来鉴定糖尿病视网膜病变的保护因子
- 批准号:90068469006846
- 财政年份:2016
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
- 批准号:89221828922182
- 财政年份:2011
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
- 批准号:82413648241364
- 财政年份:2011
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
相似海外基金
Characterizing treatment responses for common lung cancer (LC) subtypes in Latinos and Asians
描述拉丁裔和亚洲人常见肺癌 (LC) 亚型的治疗反应
- 批准号:1073339610733396
- 财政年份:2023
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Concordance with Dietary Approaches to Stop Hypertension (DASH) diet score and health outcomes among South Asians in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
居住在美国的南亚人动脉粥样硬化调节因素 (MASALA) 研究中南亚人的饮食评分与健康结果与控制高血压饮食方法 (DASH) 的一致性
- 批准号:1068780710687807
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Concordance with Dietary Approaches to Stop Hypertension (DASH) diet score and health outcomes among South Asians in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
居住在美国的南亚人动脉粥样硬化调节因素 (MASALA) 研究中南亚人的饮食评分与健康结果与控制高血压饮食方法 (DASH) 的一致性
- 批准号:1068752110687521
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Concordance with Dietary Approaches to Stop Hypertension (DASH) diet score and health outcomes among South Asians in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
居住在美国的南亚人动脉粥样硬化调节因素 (MASALA) 研究中南亚人的饮食评分与健康结果与控制高血压饮食方法 (DASH) 的一致性
- 批准号:1038615810386158
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
NYUCI-ES:通过心理社会干预改善中国和韩国 ADRD 护理人员的健康状况
- 批准号:1043745910437459
- 财政年份:2021
- 资助金额:$ 0.47万$ 0.47万
- 项目类别: